Study to Characterize the Effect of Heparin on Palifermin Activity

NCT01163097 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Oral Mucositis

Interventions

DRUG: Palifermin
DRUG: Heparin

Sponsor

Swedish Orphan Biovitrum